Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

SCM Pharma
Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693
Contact SCM Pharma
Website

 Latest Content from PMHub 

Four Health wins Judges Special Recognition Award PMEA 2019

Press Releases | November 29, 2019 | Four Agency Worldwide

We’re delighted to have won the Judge’s Special Recognition Award at the PMEA Awards 2019! Huge congratulations to the whole team for another amazing win for the GLAD I Took...

Lucid Group announces the appointment of a new Legal and Compliance manager

Press Releases | November 27, 2019 | Lucid Group Communications Limited

Lucid Group demonstrates continual investment in its infrastructure by appointing Sebastian Goodwin as its new Legal and Compliance manager.Sebastian studied politics and trained to be a lawyer before moving into...

Lucid Group Experience the Magic of Mindfulness, Meditation and Massage

Press Releases | November 27, 2019 | Lucid Group Communications Limited

This time of year can be busier than normal. Lucid Group understand the importance of taking some time out to relax and unwind. That's why yesterday, relaxation, meditation and mindfulness...

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

White Papers and Resources | November 27, 2019 | OPEN Health

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

Bedrock’s on fire for Wellbeing Week

Press Releases | November 26, 2019 | Resonant Group

Bedrock creates a positive working environment to enable individuals and our business to thrive.

WHITE PAPER: Patient nonadherence – the $637bn paradox

White Papers and Resources | November 25, 2019 | IGNIFI

What’s not changed for 50 years, kills 200,000 Europeans annually, costs pharma $637 billion and the NHS over £500 million a year? We’ll tell you.

Spotlight interview: 15 minutes on insights and market research in pharma

White Papers and Resources | November 21, 2019 | OPEN Health

Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma

Early diagnosis underpins NHS cancer strategy

White Papers and Resources | November 20, 2019 | Wilmington Healthcare

Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan

Launch Excellence 2020

White Papers and Resources | November 20, 2019 | Blue Latitude Health

In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch...

OPEN Health reflections on the World Orphan Drug Congress in Barcelona

White Papers and Resources | November 20, 2019 | OPEN Health

Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...